Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

In this virtual program faculty experts explore the use of investigational immunotherapeutic agents including monoclonal antibody&ndash based therapy immune checkpoint inhibitors vaccines and adoptive cell&ndash based therapy in treating patients with AML. Management of treatment-related toxicities will also be presented.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by an independent grant from

Helsinn Healthcare SA